Hosted on MSN4h
New Hope for Metastatic Colorectal Cancer Patients: A Targeted Approach With a Drug Called Encorafenib Gets FDA Approval
A groundbreaking FDA approval has introduced a new treatment option specifically designed for colorectal cancer patients with ...
Hosted on MSN6h
Pharma Stock Roundup: NVO's Obesity Study Failure, FDA Nod to PFE, LLY
Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...